Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance

Abstract : Anti-apoptotic BCL-2 family members bind to BH3-only proteins and multidomain BAX/BAK to preserve mitochondrial integrity and maintain survival. Whereas inhibition of these interactions is the biological basis of BH3-mimetic anti-cancer therapy, the actual response of membrane-bound protein complexes to these compounds is currently ill-defined. Here, we find that treatment with BH3 mimetics targeting BCL-xL spares subsets of cells with the highest levels of this protein. In intact cells, sequestration of some pro-apoptotic activators (including PUMA and BIM) by full-length BCL-xL is much more resistant to derepression than previously described in cell-free systems. Alterations in the BCL-xL C-terminal anchor that impacts subcellular membrane-targeting and localization dynamics restore sensitivity. Thus, the membrane localization of BCL-xL enforces its control over cell survival and, importantly, limits the pro-apoptotic effects of BH3 mimetics by selectively influencing BCL-xL binding to key proapoptotic effectors.
Document type :
Journal articles
Complete list of metadatas

https://www.hal.inserm.fr/inserm-01416194
Contributor : Elizabeth Bernardo <>
Submitted on : Wednesday, December 14, 2016 - 10:56:19 AM
Last modification on : Thursday, February 7, 2019 - 4:36:41 PM
Long-term archiving on : Wednesday, March 15, 2017 - 1:10:54 PM

File

CellRep2016Eq8.pdf
Files produced by the author(s)

Identifiers

Collections

Citation

Jessie Pécot, Laurent Maillet, Janic Le Pen, Céline Vuillier, Sophie de Carné Trécesson, et al.. Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance. Cell Reports , Elsevier Inc, 2016, ⟨10.1016/j.celrep.2016.11.064⟩. ⟨inserm-01416194⟩

Share

Metrics

Record views

441

Files downloads

264